Cargando…
Self‐reported cognitive impairments and quality of life in patients with gastrointestinal stromal tumor: Results of a multinational survey
BACKGROUND: Cancer‐related cognitive impairment (CRCI) has long‐term effects on survivor quality of life, but CRCI research on patients with gastrointestinal stromal tumor (GIST) is lacking. The aims of this study were to investigate CRCI and concomitant quality of life among patients with GIST. MET...
Autores principales: | Ferguson, Robert J., Manculich, Jessica, Chang, Hsuan, Sareen, Nikita J., Snitz, Beth E., Terhorst, Lauren, Bovbjerg, Dana H., Duensing, Anette U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633548/ https://www.ncbi.nlm.nih.gov/pubmed/36125989 http://dx.doi.org/10.1002/cncr.34469 |
Ejemplares similares
-
Bortezomib: killing two birds with one stone in gastrointestinal stromal tumors
por: Duensing, Stefan, et al.
Publicado: (2010) -
Using Single-Case Experimental Design and Patient-Reported Outcome Measures to Evaluate the Treatment of Cancer-Related Cognitive Impairment in Clinical Practice
por: Ferguson, Robert J., et al.
Publicado: (2023) -
Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal tumor (GIST) cells to imatinib mesylate
por: Rausch, Jessica L., et al.
Publicado: (2016) -
Targeting the translational machinery in gastrointestinal stromal tumors (GIST): a new therapeutic vulnerability
por: Lee, Donna M., et al.
Publicado: (2022) -
Differential antitumor activity of compounds targeting the ubiquitin-proteasome machinery in gastrointestinal stromal tumor (GIST) cells
por: Rausch, Jessica L., et al.
Publicado: (2020)